Determinants and consequences of renal function variations with aldosterone blocker therapy in heart failure patients after myocardial infarction: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Determinants and consequences of renal function variations with aldosterone blocker therapy in heart failure patients after myocardial infarction : insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study. / Rossignol, Patrick; Cleland, John G F; Bhandari, Sunil; Tala, Stéphane; Gustafsson, Finn; Fay, Renaud; Lamiral, Zohra; Dobre, Daniela; Pitt, Bertram; Zannad, Faiez.

I: Circulation, Bind 125, Nr. 2, 2012, s. 271-9.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Rossignol, P, Cleland, JGF, Bhandari, S, Tala, S, Gustafsson, F, Fay, R, Lamiral, Z, Dobre, D, Pitt, B & Zannad, F 2012, 'Determinants and consequences of renal function variations with aldosterone blocker therapy in heart failure patients after myocardial infarction: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study', Circulation, bind 125, nr. 2, s. 271-9. https://doi.org/10.1161/CIRCULATIONAHA.111.028282

APA

Rossignol, P., Cleland, J. G. F., Bhandari, S., Tala, S., Gustafsson, F., Fay, R., Lamiral, Z., Dobre, D., Pitt, B., & Zannad, F. (2012). Determinants and consequences of renal function variations with aldosterone blocker therapy in heart failure patients after myocardial infarction: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study. Circulation, 125(2), 271-9. https://doi.org/10.1161/CIRCULATIONAHA.111.028282

Vancouver

Rossignol P, Cleland JGF, Bhandari S, Tala S, Gustafsson F, Fay R o.a. Determinants and consequences of renal function variations with aldosterone blocker therapy in heart failure patients after myocardial infarction: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study. Circulation. 2012;125(2):271-9. https://doi.org/10.1161/CIRCULATIONAHA.111.028282

Author

Rossignol, Patrick ; Cleland, John G F ; Bhandari, Sunil ; Tala, Stéphane ; Gustafsson, Finn ; Fay, Renaud ; Lamiral, Zohra ; Dobre, Daniela ; Pitt, Bertram ; Zannad, Faiez. / Determinants and consequences of renal function variations with aldosterone blocker therapy in heart failure patients after myocardial infarction : insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study. I: Circulation. 2012 ; Bind 125, Nr. 2. s. 271-9.

Bibtex

@article{9c4955f6709243e5ae71a9a002ed6f7d,
title = "Determinants and consequences of renal function variations with aldosterone blocker therapy in heart failure patients after myocardial infarction: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study",
abstract = "We evaluated the effect of the selective mineralocorticoid receptor antagonist eplerenone on renal function and the interaction between changes in renal function and subsequent cardiovascular outcomes in patients with heart failure and left ventricular systolic dysfunction after an acute myocardial infarction in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS).",
author = "Patrick Rossignol and Cleland, {John G F} and Sunil Bhandari and St{\'e}phane Tala and Finn Gustafsson and Renaud Fay and Zohra Lamiral and Daniela Dobre and Bertram Pitt and Faiez Zannad",
note = "{\textcopyright} 2011 American Heart Association, Inc.",
year = "2012",
doi = "10.1161/CIRCULATIONAHA.111.028282",
language = "English",
volume = "125",
pages = "271--9",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams & Wilkins",
number = "2",

}

RIS

TY - JOUR

T1 - Determinants and consequences of renal function variations with aldosterone blocker therapy in heart failure patients after myocardial infarction

T2 - insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study

AU - Rossignol, Patrick

AU - Cleland, John G F

AU - Bhandari, Sunil

AU - Tala, Stéphane

AU - Gustafsson, Finn

AU - Fay, Renaud

AU - Lamiral, Zohra

AU - Dobre, Daniela

AU - Pitt, Bertram

AU - Zannad, Faiez

N1 - © 2011 American Heart Association, Inc.

PY - 2012

Y1 - 2012

N2 - We evaluated the effect of the selective mineralocorticoid receptor antagonist eplerenone on renal function and the interaction between changes in renal function and subsequent cardiovascular outcomes in patients with heart failure and left ventricular systolic dysfunction after an acute myocardial infarction in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS).

AB - We evaluated the effect of the selective mineralocorticoid receptor antagonist eplerenone on renal function and the interaction between changes in renal function and subsequent cardiovascular outcomes in patients with heart failure and left ventricular systolic dysfunction after an acute myocardial infarction in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS).

U2 - 10.1161/CIRCULATIONAHA.111.028282

DO - 10.1161/CIRCULATIONAHA.111.028282

M3 - Journal article

C2 - 22128223

VL - 125

SP - 271

EP - 279

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 2

ER -

ID: 48457795